Arbor Vita Corporation Navigation
  • CoVisa™ IgG Test
  • OncoE6™ Cervical Test
  • News
  • Products
  • About
  • Contact
  • Search
  • CoVisa™ IgG Test
  • OncoE6™ Cervical Test
  • News
  • Products
  • About
  • Contact
  • Search

News & Updates The latest coverage and press releases on Arbor Vita Corporation’s medical advances —plus related health news and happenings from around the globe.
View Post

Arbor Vita Launches Open Platform COVID-19 Antibody Test Expanding Access To Higher Quality Diagnostics

In CoVisa, Press Release by Bryan Beacraft06/08/2020

The CoVisa™ IgG ELISA-based test enables widely available ELISA systems to add capacity to the high-quality closed testing platforms currently in place FREMONT Calif., …

Read More
View Post

When It Comes To Cervical Cancer, Two Tests Are Better — And Cheaper — Than One

In Related News by Bryan Beacraft07/11/2016

It is right that we constantly should be testing our assumptions about what keeps us healthy and what puts us at risk. New ideas …

Read More
View Post

The days of the dreaded annual pelvic exam for women may be numbered

In Related News by Bryan Beacraft06/30/2016

There’s great news for women who dread that annual pelvic exam (i.e. basically everyone). On Tuesday, a panel made up of medical experts that …

Read More
View Post

Global Health Resident to Lead Cervical Cancer Project Funded by a Grand Challenges Explorations Grant

In Press Release by Bryan Beacraft06/06/2016

Laura Musselwhite, an internal medicine resident in the Hubert-Yeargan Center’s Global Health Pathway, will be the principal investigator for a recently awarded Grand Challenges …

Read More
View Post

Rise in Early Cervical Cancer Detection Is Linked to Affordable Care Act

In Related News by arborvita_admin03/18/2016

Researchers used the National Cancer Data Base, a hospital-based registry of about 70 percent of all cancer cases in the United States. They compared …

Read More
  • Page 1 of 3
  • 1
  • 2
  • 3
  • →

For Professionals

  • Feasibility Study of a Human Papillomavirus E6 Oncoprotein Test for Diagnosis of Cervical Precancer and Cancer
  • Clinical Test for HPV Induced Cancer in Low Resource Settings Via Direct Detection of Elevated HPV E6 Oncoprotein
  • Effectiveness of novel, lower cost molecular human papillomavirus-based tests for cervical cancer screening in rural china
  • Formation of well-defined soluble aggregates upon fusion to MBP is a generic property of E6 proteins from various human papillomavirus species
  • The Human Papillomavirus E6 Oncogene Dysregulates the Cell Cycle and Contributes to Cervical Carcinogenesis through Two Independent Activities

About Arbor Vita

  • Support
  • Careers
  • Terms and Conditions

Location

Arbor Vita Corporation
48371 Fremont Blvd, Suite 101
Fremont, CA 94538
USA

Contact Us

Phone: +1 (408) 585-3900
Fax: +1 (408) 585-3901
Email: info@arborvita.com

Social Media

Twitter
  • Twitter
  • LinkedIn